Biotechnology company focused on metabolism and rejuvenation
MPC Therapeutics has raised €1.5M across 1 funding round from 2 investors, most recently a Seed round in Jan 2023. Based in Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-10 | Seed | €1.5M |
| Angel Investors,Plutus Investment Group |
| View deal → |
